website2646Aug 17, 20221 min readBMS acquisition of Turning Point Therapeutics at US$4.1 B closed on 8/15/2022https://news.bms.com/news/details/2022/Bristol-Myers-Squibb-and-Turning-Point-Therapeutics-Announce-Expiration-of-HSR-Act-Waiting-Period-and-Clearance-from-Federal-Cartel-Office-of-Germany-Related-to-Pending-Acquisition-of-Turning-Point-Therapeutics/default.aspx
https://news.bms.com/news/details/2022/Bristol-Myers-Squibb-and-Turning-Point-Therapeutics-Announce-Expiration-of-HSR-Act-Waiting-Period-and-Clearance-from-Federal-Cartel-Office-of-Germany-Related-to-Pending-Acquisition-of-Turning-Point-Therapeutics/default.aspx
Syncell won the 2023 BioTech Breakthrough Awards’ "Proteomics Innovation of the Year" award2023 Winners - BioTech Breakthrough Awards
【植物肉超級進化】路易莎、Lypid、大成三強聯手 植物肉台灣隊單挑國際一級大廠https://tw.stock.yahoo.com/news/%E6%A4%8D%E7%89%A9%E8%82%89%E8%B6%85%E7%B4%9A%E9%80%B2%E5%8C%96-%E8%B7%AF%E6%98%93%E8%8E%8E-lypid-%E5%A4%A7%E6%88%90%E4%B8%89%E5%BC%B7%E8%81%AF%E6%89%8B-%E6%A4%8D%E7%89
